Singulair vs inhaled corticosteroid

In another randomized, placebo-controlled, parallel-group trial (n=642) in a similar population of adult patients previously maintained, but not adequately controlled, on inhaled corticosteroids (beclomethasone 336 mcg/day), the addition of SINGULAIR to beclomethasone resulted in statistically significant improvements in FEV 1 compared with those patients who were continued on beclomethasone alone or those patients who were withdrawn from beclomethasone and treated with montelukast or placebo alone over the last 10 weeks of the 16-week, blinded treatment period. Patients who were randomized to treatment arms containing beclomethasone had statistically significantly better asthma control than those patients randomized to SINGULAIR alone or placebo alone as indicated by FEV 1 , daytime asthma symptoms, PEFR, nocturnal awakenings due to asthma, and “as-needed” β-agonist requirements.

Singulair vs inhaled corticosteroid

singulair vs inhaled corticosteroid

Media:

singulair vs inhaled corticosteroidsingulair vs inhaled corticosteroidsingulair vs inhaled corticosteroidsingulair vs inhaled corticosteroidsingulair vs inhaled corticosteroid

http://buy-steroids.org